Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nephros Inc (NEPH)

Nephros Inc (NEPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,453
  • Shares Outstanding, K 9,962
  • Annual Sales, $ 8,560 K
  • Annual Income, $ -4,770 K
  • 60-Month Beta 1.37
  • Price/Sales 10.69
  • Price/Cash Flow N/A
  • Price/Book 5.93
Trade NEPH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +57.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.26 +23.97%
on 05/17/21
9.35 -3.74%
on 06/08/21
+1.35 (+17.65%)
since 05/14/21
3-Month
6.24 +44.23%
on 03/31/21
9.35 -3.74%
on 06/08/21
+1.62 (+21.95%)
since 03/15/21
52-Week
5.08 +77.12%
on 09/25/20
9.35 -3.74%
on 06/08/21
+1.00 (+12.50%)
since 06/15/20

Most Recent Stories

More News
What Makes Nephros Inc. (NEPH) a Good Fit for "Trend Investing"

Nephros Inc. (NEPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through...

NEPH : 9.00 (-1.96%)
Nephros Inc. (NEPH) Reports Q1 Loss, Tops Revenue Estimates

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 57.14% and 1.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

NEPH : 9.00 (-1.96%)
Nephros Announces Results for Quarter Ended March 31, 2021

Net Revenue of $2.7 Million; Highest First Quarter in Company History

NEPH : 9.00 (-1.96%)
Nephros Announces First Quarter 2021 Financial Results Conference Call

via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial results on Thursday, May 6, 2021 after market close and...

NEPH : 9.00 (-1.96%)
Nephros Announces Preliminary Results for First Quarter of 2021

Anticipates Net Revenue of $2.7 Million; Highest First Quarter in Company History

NEPH : 9.00 (-1.96%)
Nephros to Present at the Q1 Virtual Investor Summit

via InvestorWire - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy...

NEPH : 9.00 (-1.96%)
Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy...

NEPH : 9.00 (-1.96%)
Nephros Inc. (NEPH) Reports Q4 Loss, Tops Revenue Estimates

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 33.33% and 1.92%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

NEPH : 9.00 (-1.96%)
Nephros Reports 2020 Fourth Quarter and Full Year Financial Results

Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third Quarter

NEPH : 9.00 (-1.96%)
Nephros, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Nephros, Inc. (NASDAQ:NEPH) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 1, 2021 at 4:30 PM Eastern...

NEPH : 9.00 (-1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider.

See More

Key Turning Points

3rd Resistance Point 9.37
2nd Resistance Point 9.28
1st Resistance Point 9.14
Last Price 9.00
1st Support Level 8.92
2nd Support Level 8.83
3rd Support Level 8.69

See More

52-Week High 9.35
Last Price 9.00
Fibonacci 61.8% 7.72
Fibonacci 50% 7.22
Fibonacci 38.2% 6.71
52-Week Low 5.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar